Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.6 - $1.31 $87,216 - $190,421
145,360 Added 12.17%
1,339,331 $1.15 Million
Q3 2023

Nov 13, 2023

BUY
$1.05 - $3.37 $57,884 - $185,781
55,128 Added 4.84%
1,193,971 $1.28 Million
Q2 2023

Aug 07, 2023

BUY
$2.44 - $4.53 $488,997 - $907,852
200,409 Added 21.36%
1,138,843 $2.95 Million
Q1 2023

May 11, 2023

BUY
$3.72 - $5.4 $1.33 Million - $1.93 Million
357,211 Added 61.46%
938,434 $3.82 Million
Q4 2022

Feb 14, 2023

BUY
$3.41 - $12.93 $1.98 Million - $7.52 Million
581,223 New
581,223 $2.91 Million
Q2 2022

Aug 09, 2022

BUY
$10.58 - $17.5 $16,536 - $27,352
1,563 Added 10.31%
16,716 $214,000
Q1 2022

May 12, 2022

BUY
$13.81 - $18.6 $185,233 - $249,481
13,413 Added 770.86%
15,153 $230,000
Q4 2021

Feb 10, 2022

BUY
$17.26 - $22.02 $30,032 - $38,314
1,740 New
1,740 $30,000
Q3 2021

Nov 12, 2021

SELL
$20.15 - $26.19 $86,745 - $112,747
-4,305 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$15.06 - $30.03 $64,833 - $129,279
4,305 New
4,305 $85,000
Q3 2020

Nov 09, 2020

SELL
$15.59 - $19.97 $147,356 - $188,756
-9,452 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$11.97 - $23.47 $49,184 - $96,438
4,109 Added 76.9%
9,452 $186,000
Q1 2020

May 11, 2020

BUY
$10.0 - $19.51 $53,430 - $104,241
5,343 New
5,343 $66,000

Others Institutions Holding NGM

About NGM BIOPHARMACEUTICALS INC


  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.